Clinical trial
Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke
NCT00452582 · Henry Ford Health System, Other · Terminated
Key facts
| NCT number | NCT00452582 |
|---|---|
| Title | Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke |
| Official title | Phase 1 Study of Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke |
| Lead sponsor | Henry Ford Health System, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Drug, Other |
| Interventions | Sildenafil (Viagra), Usual care |
| Enrollment | 20 |
| Start date | Apr 1, 2005 |
| First posted | Mar 27, 2007 |
| Last update posted | Mar 16, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: